Skip to Content

Watson 371 25 mg (Loxapine Succinate 25 mg)

Pill with imprint Watson 371 25 mg is Green & White, Capsule-shape and has been identified as Loxapine Succinate 25 mg. It is supplied by Watson Laboratories, Inc..

Loxapine is used in the treatment of agitated state; agitation; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Watson 371 25 mg

Loxapine succinate 25 mg Watson 371 25 mg
Loxapine succinate 25 mg Watson 371 25 mg
Loxapine succinate 25 mg Watson 371 25 mg

Loxapine Succinate

Imprint
Watson 371 25 mg
Strength
25 mg
Color
Green & White
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous antipsychotic agents
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
lactose anhydrous, benzyl alcohol, butylparaben, edetate calcium disodium, gelatin, magnesium stearate, methylparaben, polacrilin potassium, propylparaben, sodium lauryl sulfate, sodium propionate, magnesium silicate, titanium dioxide, D&C Yellow No. 10, FD&C Blue No. 1

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-0371 Watson Pharmaceuticals, Inc.
51079-0902 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.